Technology

INmune Bio And Quantum Computing Inc. Partner To Use Quantum AI To Identify New Treatment Applications For Alzheimer’s Drug XPro

Oct 14, 2026 · 08:35 AM ET· updated 1h ago

Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XProInitial engagement marks QCi's

Why It Matters

INmune Bio and Quantum Computing are working together to find new uses for an Alzheimer's drug. This partnership shows how new computer technology might help discover treatments faster.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

INMB1.82

+0.14 (+8.33%)

QUBT6.62

-0.25 (-3.64%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.